DE69727582D1 - Test zur quantifizierung von arthritiszustanden - Google Patents

Test zur quantifizierung von arthritiszustanden

Info

Publication number
DE69727582D1
DE69727582D1 DE69727582T DE69727582T DE69727582D1 DE 69727582 D1 DE69727582 D1 DE 69727582D1 DE 69727582 T DE69727582 T DE 69727582T DE 69727582 T DE69727582 T DE 69727582T DE 69727582 D1 DE69727582 D1 DE 69727582D1
Authority
DE
Germany
Prior art keywords
adp
molecular weight
body fluid
fluid sample
measure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69727582T
Other languages
English (en)
Other versions
DE69727582T2 (de
Inventor
Vishwas Ganu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of DE69727582D1 publication Critical patent/DE69727582D1/de
Publication of DE69727582T2 publication Critical patent/DE69727582T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/105—Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525—Stabilizing or preserving
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction
DE69727582T 1996-08-15 1997-08-08 Test zur quantifizierung von arthritiszustanden Expired - Fee Related DE69727582T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2404196P 1996-08-15 1996-08-15
US24041P 1996-08-15
PCT/EP1997/004316 WO1998007035A1 (en) 1996-08-15 1997-08-08 Assay for quantifying arthritic conditions

Publications (2)

Publication Number Publication Date
DE69727582D1 true DE69727582D1 (de) 2004-03-18
DE69727582T2 DE69727582T2 (de) 2004-12-23

Family

ID=21818539

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69727582T Expired - Fee Related DE69727582T2 (de) 1996-08-15 1997-08-08 Test zur quantifizierung von arthritiszustanden

Country Status (7)

Country Link
US (1) US6589755B1 (de)
EP (1) EP0922225B1 (de)
JP (1) JP4189033B2 (de)
AT (1) ATE259505T1 (de)
AU (1) AU4298297A (de)
DE (1) DE69727582T2 (de)
WO (1) WO1998007035A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788603B1 (fr) * 1999-01-20 2001-04-13 Covalab PROCEDE D'IMMUNOANALYSE D'UNE PROTEINE MATRICIELLE OLIGOMERIQUE DU CARTILAGE -comp-, SONDE ANTIGENIQUE, ANTICORPS ET NECESSAIRE D'IMMUNOANALYSE UTILISE POUR LA MISE EN OEUVRE DE CE PROCEDE
US6849594B1 (en) 1999-06-30 2005-02-01 John Lawler Purification and use of human recombinant cartilage oligomeric matrix protein
SE9904236D0 (sv) 1999-11-22 1999-11-22 Ana Mar Diagnostics Ab Immunoassay
US20030119074A1 (en) * 2001-12-20 2003-06-26 George Jackowski Diagnosis and treatment of dementia utilizing thrombospondin
JP2003307517A (ja) * 2002-04-16 2003-10-31 Inst Of Physical & Chemical Res Ｃｏｍｐ異常症の検査方法
US7655411B2 (en) 2002-08-23 2010-02-02 W2 Holdings, Inc. Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer
EP1766411B1 (de) * 2004-05-24 2011-02-23 AnaMar AB Verfahren zur bestimmung eines gewebeabbauverfahrens durch nachweis von comp-neoepitopen
WO2006044946A2 (en) * 2004-10-20 2006-04-27 Onco Detectors International, Llc Migration inhibitory factor in serum as a tumor marker for prostate, bladder, breast, ovarian, kidney and lung cancer
WO2008156865A2 (en) * 2007-06-20 2008-12-24 Schering Corporation Joint destruction biomarkers for anti-il-17a therapy of inflammatory joint disease
US9632097B2 (en) 2012-06-28 2017-04-25 Nordic Boiscience A/S Determining pathological cartilage turnover
EP3015069A1 (de) 2014-10-30 2016-05-04 Universitätsklinikum Jena Vorrichtung für hängende Ultrasonografie und zugehöriges Verfahren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8304836D0 (sv) * 1983-09-09 1983-09-09 Pharmacia Ab Sett att bestemma forendringar i ledbrosk
US4610960A (en) * 1983-12-21 1986-09-09 Wisconsin Alumni Research Foundation Monoclonal antibody to thrombospondin and method for assaying for and isolating thrombospondin
US5948692A (en) * 1994-02-19 1999-09-07 Seikagaku Corporation Method and measurement kit for assay of normal agrecan, and method for evaluation of informations on the joint
US5753230A (en) * 1994-03-18 1998-05-19 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis
AUPM666894A0 (en) * 1994-07-07 1994-07-28 University Of Melbourne, The Diagnostic methods and compositions

Also Published As

Publication number Publication date
DE69727582T2 (de) 2004-12-23
EP0922225B1 (de) 2004-02-11
JP4189033B2 (ja) 2008-12-03
JP2000517418A (ja) 2000-12-26
ATE259505T1 (de) 2004-02-15
WO1998007035A1 (en) 1998-02-19
AU4298297A (en) 1998-03-06
EP0922225A1 (de) 1999-06-16
US6589755B1 (en) 2003-07-08

Similar Documents

Publication Publication Date Title
US4732863A (en) PEG-modified antibody with reduced affinity for cell surface Fc receptors
Kemshead et al. Human Thy-1: Expression on the cell surface of neuronal and and glial cells
EP2853898A1 (de) Analyse von Myostatin im Serum
DE69333641T2 (de) Methode zur messung der knochenresorption
US5726061A (en) Method of diagnosing and monitoring colorectal cancer
DE69727582D1 (de) Test zur quantifizierung von arthritiszustanden
JP5930086B2 (ja) β−グルカンの測定方法及びそれに用いられるβ−グルカン結合性蛋白質
Suzuki et al. Identification of a protein having hemagglutinating activity in the hemolymph of the silkworm, Bombyx mori
Lafaye et al. Fixation of penicilloyl groups to albumin and appearance of anti-penicilloyl antibodies in penicillin-treated patients.
Maizels et al. Secreted and circulating antigens of the filarial parasite Brugia pahangi: analysis of in vitro released components and detection of parasite products in vivo
Wessels et al. Different localization of dystrophin in developing and adult human skeletal muscle
DE69024043D1 (de) Monoklonaler antikörper mit erkennungsspezifität für ein glykoprotein des globulären membran-mucin-antigens aus menschlichem milchfett.
Gaffney et al. Monoclonal antibodies to crosslinked fibrin degradation products (XL‐FDP) I. CHARACTERIZATION AND PRELIMINARY EVALUATION IN PLASMA
US4826776A (en) Method for determining hyaluronic acid, and a reagent kit for said method
CA2348545A1 (en) A complex of a chaperone with .beta.-amyloid and methods employing this complex
CA2524002A1 (en) Sars-related proteins
US7812125B2 (en) Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
JP2003315334A (ja) 体液中のｂｐｉの定量方法
CN1429845A (zh) 鼠抗氯霉素单克隆抗体及其用途
Jenkins et al. HPLC purification of recombinant NcGRA6 antigen improves enzyme-linked immunosorbent assay for serodiagnosis of bovine neosporosis
Akimoto et al. Relationship between clinical features and binding domains of anti-prothrombin autoantibodies in patients with systemic lupus erythematosus and antiphospholipid syndrome
KR900013987A (ko) 망막아종 유전자 생성물에 대한 항체 및 이의 용도
DE69730223D1 (de) Diagnostische methode zum nachweis von isoformen des eosinophilen kationischen proteins
Venge et al. HNL Dimer-A Specific Biomarker of Neutrophil Activity In Sepsis and Antibiotics Monitoring. A Mini-Review
Wee et al. Enzyme-linked immunosorbent assay for detection of Trichinella spiralis antibodies and the surveillance of selected pig breeding farms in the Republic of Korea

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee